Featured Research

from universities, journals, and other organizations

Powerful class of antioxidants may be potent Parkinson's treatment

Date:
July 23, 2012
Source:
Georgia Health Sciences University
Summary:
A new and powerful class of antioxidants could one day be a potent treatment for Parkinson's disease, researchers report.

A new and powerful class of antioxidants could one day be a potent treatment for Parkinson's disease, researchers report.

Related Articles


A class of antioxidants called synthetic triterpenoids blocked development of Parkinson's in an animal model that develops the disease in a handful of days, said Dr. Bobby Thomas, neuroscientist at the Medical College of Georgia at Georgia Health Sciences University and corresponding author of the study in the journal Antioxidants & Redox Signaling.

Thomas and his colleagues were able to block the death of dopamine-producing brain cells that occurs in Parkinson's by using the drugs to bolster Nrf2, a natural antioxidant and inflammation fighter.

Stressors from head trauma to insecticide exposure to simple aging increase oxidative stress and the body responds with inflammation, part of its natural repair process. "This creates an environment in your brain that is not conducive for normal function," Thomas said. "You can see the signs of oxidative damage in the brain long before the neurons actually degenerate in Parkinson's."

Nrf2, the master regulator of oxidative stress and inflammation, is -- inexplicably -- significantly decreased early in Parkinson's. In fact, Nrf2 activity declines normally with age.

"In Parkinson's patients you can clearly see a significant overload of oxidative stress, which is why we chose this target," Thomas said. "We used drugs to selectively activate Nrf2."

They parsed a number of antioxidants already under study for a wide range of diseases from kidney failure to heart disease and diabetes, and found triterpenoids the most effective on Nrf2. Co-author Dr. Michael Sporn, Professor of Pharmacology, Toxicology and Medicine at Dartmouth Medical School, chemically modified the agents so they could permeate the protective blood-brain barrier.

Both in human neuroblastoma and mouse brain cells they were able to document an increase in Nrf2 in response to the synthetic triterpenoids. Human dopaminergic cells are not available for research so the scientists used the human neuroblastoma cells, which are actually cancer cells that have some properties similar to neurons.

Their preliminary evidence indicates the synthetic triterpenoids also increase Nrf2 activity in astrocytes, a brain cell type which nourishes neurons and hauls off some of their garbage. The drugs didn't protect brain cells in an animal where the Nrf2 gene was deleted, more proof that that Nrf2 is the drugs' target.

The researchers used the powerful neurotoxin MPTP to mimic Parkinson's-like brain cell damage in a matter of days. They are now looking at the impact of synthetic triterpenoids in an animal model genetically programmed to acquire the disease more slowly, as humans do. Collaborators at Johns Hopkins School of Medicine also will be providing induced pluripotent stem cells, adult stem cells that can be coaxed into forming dopaminergic neurons, for additional drug testing.

Other collaborators include scientists at Weill Medical College of Cornell University, Johns Hopkins School of Public Health, Moscow State University, Tohoku University and the University of Pittsburgh.


Story Source:

The above story is based on materials provided by Georgia Health Sciences University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Navneet Ammal Kaidery, Rebecca Banerjee, Lichuan Yang, Natalya A Smirnova, Dmitry M Hushpulian, Karen T Liby, Charlotte W Williams, Masayuki Yamamoto, Thomas W. Kensler, RAJIV RATAN, Michael B Sporn, Flint Beal, Irina G Gazaryan, Bobby Thomas. Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP- mouse model of Parkinson’s disease. Antioxidants & Redox Signaling, 2012; 120701083204005 DOI: 10.1089/ars.2011.4491

Cite This Page:

Georgia Health Sciences University. "Powerful class of antioxidants may be potent Parkinson's treatment." ScienceDaily. ScienceDaily, 23 July 2012. <www.sciencedaily.com/releases/2012/07/120723134755.htm>.
Georgia Health Sciences University. (2012, July 23). Powerful class of antioxidants may be potent Parkinson's treatment. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/2012/07/120723134755.htm
Georgia Health Sciences University. "Powerful class of antioxidants may be potent Parkinson's treatment." ScienceDaily. www.sciencedaily.com/releases/2012/07/120723134755.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins